GLI - Go Life International Ld
Go Life International was established to leverage the strength of existing South African nutraceutical companies, Go Life Health Products and Gotha Health Products (collectively Go Life SA), and to drive the presence of the South African products and brands across the global nutraceutical market.
Go Life International PCC is an investment holding group. It is principally engaged in the distribution of health products including natural products, supplements, and cosmeceuticals. The brands of the group are Go Life Health Products...
|Live Trading Feed|
|Day’s Low Price|
|Day’s High Price|
|Number of Deals||0|
|Growth & Valuation|
|Earnings Per Share||0.0014|
|Dividend Per Share|
GLI Stock Market Performance
The current share price of Go Life International Ld (GLI) is ZAR 0.01. GLI closed its last trading day (Monday, September 20, 2021) at 0.01 ZAR per share on the Johannesburg Stock Exchange (JSE). Go Life International Ld began the year with a share price of 0.03 ZAR but has since lost 66.7% off that price valuation, ranking it 423rd on the JSE in terms of year-to-date performance.
Go Life International Ld is the 112th most traded stock on the Johannesburg Stock Exchange over the past three months (Jun 23 - Sep 20, 2021). GLI has traded a total volume of 38 million shares—in 80 deals—valued at ZAR 409,611 over the period, with an average of 603,820 traded shares per session. A volume high of 4.2 million was achieved on July 12th for the same period. The table below details the last 10 trading days of activity of Go Life International Ld on the Johannesburg Stock Exchange.
Profile of Go Life International Ltd.
Go Life International Ltd. operates in the Health Care sector, specifically, the Pharmaceuticals & Biotechnology industry.
|Factsheet of Go Life International Ltd.|
Pharmaceuticals & Biotechnology
2nd Floor, Merrick, House 12 Long Street, Knysna
GLI Industrial Market Competitors
Go Life International Ltd., issuers of the GLI stock on the Johannesburg Stock Exchange, have a number of market competitors who are also engaged in the Health Care sector and/or Pharmaceuticals & Biotechnology industry. The table below presents an overview of the market standing of the top nine by year-to-date performance.
|APN||Aspen Pharmacare Holdings||109B||238.67||+90.4%|
|AIP||Adcock Ingram Hldgs Ltd||8.15B||46.38||+0.83%|
|ASC||Ascendis Health Ltd||255M||0.52||-30.7%|
|LHC||Life Healthcare Group Holdings||35.4B||24.10||+43.3%|
|ACT||AfroCentric Inv Corp Ltd||3.06B||5.32||+40%|
|AVL||Advanced Health Limited||209M||0.42||+40%|
|NTCP||Netcare Limited Pref||115B||80.00||+27%|
|MEI||Mediclinic Int plc||46.3B||62.84||+10.4%|